Skip to content

EMEUNEWS

Search
  • Congress Topics
    • Basic Research
    • Imaging
    • Metabolic and Crystal Arthropathies
    • Paediatric Rheumatology
    • Rare and Autoinflammatory Diseases
    • Rheumatoid Arthritis I – Clinical (non-therapeutic)
    • Rheumatoid arthritis II – therapeutic
    • Spondyloarthritis I – non-therapeutic
    • Spondyloarthritis II – therapeutic
  • Featured Content
    • ACR Highlights
  • Press Review
    • Annals of the Rheumatic Diseases
    • RMD Open
    • Arthritis and Rheumatology
    • Rheumatology (Oxford)
    • Arthritis Research and Therapy
    • Arthritis Care and Research
    • Seminars in Arthritis and Rheumatism
    • The Lancet Rheumatology
    • Miscellaneous
  • About EMEUNEWS
  • About EMEUNET
  • Contact Us
  • Subscribe here!

Category: Osteoarthritis and Osteoporosis

Osteoarthritis and Osteoporosis

[EULAR HL 2023] Osteoarthritis & Osteoporosis

20 Jun 2023
Author: Anastasia Madenidou Wittoek et al. (OP0071) explored the benefits of denosumab in patients with erosive hand OA. One hundred patients with erosive hand OA were randomly allocated to placebo…
Osteoarthritis and Osteoporosis

Osteoarthritis & Osteoporosis

29 May 202329 May 2023
Zoran Veličković Zoran is a Internal Medicine Resident at Institute of Rheumatology, School of Medicine, University of Belgrade, undertaking a PhD at the same institution. His work primarily focuses on…

Seestrasse 240
CH 8802 Kilchberg (ZH)
Switzerland
emeunet@eular.ch
emeunet.eular.org

About EULAR
The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations.
Visit website here

About EMEUNET
EMEUNET is an exciting community that started its activities in 2009, emanating from one of the objectives set by EULAR – "Bring on board high quality, young generation contributors in all EULAR activities".
Visit website here

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • Spotify
 

Loading Comments...